Eledon Pharmaceuticals Inc
NASDAQ:ELDN

Watchlist Manager
Eledon Pharmaceuticals Inc Logo
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
Watchlist
Price: 4.36 USD 3.32% Market Closed
Market Cap: 260.5m USD
Have any thoughts about
Eledon Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

ELDN Price Targets Summary
Eledon Pharmaceuticals Inc

Wall Street analysts forecast ELDN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELDN is 12.75 USD with a low forecast of 7.07 USD and a high forecast of 21.53 USD.

Lowest
Price Target
7.07 USD
62% Upside
Average
Price Target
12.75 USD
192% Upside
Highest
Price Target
21.53 USD
394% Upside
Eledon Pharmaceuticals Inc Competitors:
Price Targets
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
17% Downside
QNCX
Quince Therapeutics Inc
416% Upside
084650
Labgenomics Co Ltd
108% Upside
AZT
Arcticzymes Technologies ASA
29% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
28% Upside
BCYC
Bicycle Therapeutics PLC
164% Upside
NRIX
Nurix Therapeutics Inc
65% Upside
MNKD
MannKind Corp
33% Upside

Revenue
Forecast

Revenue Estimate
Eledon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Eledon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Eledon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ELDN's stock price target?
Price Target
12.75 USD

According to Wall Street analysts, the average 1-year price target for ELDN is 12.75 USD with a low forecast of 7.07 USD and a high forecast of 21.53 USD.

Back to Top